Cedars-Sinai Medical Center's Louis Warschaw Prostate Cancer Center at the Samuel Oschin Comprehensive Cancer Institute in Los Angeles is seeking participants for its Prostate Patient Profiles Project, in conjunction with Centinela Freeman Regional Medical Center, Memorial Campus in Inglewood.
Chronic foot pain sidelined a normally active Georgia woman after bunion surgery. Initially diagnosed with an unrelated and incurable nerve problem, she sought a second opinion at Cedars-Sinai Medical Center in Los Angeles. Using advanced tests, orthopedic surgeons there confirmed that the nerves in her foot were normal, but that she needed another surgery to remove part of a bone that had become infected since the first surgery. After the second surgery (which included transplanting healthy bone harvested from her other foot), she was walking without pain within three months.
In the first large-scale study of its kind, researchers at Cedars-Sinai found that people suffering from resistant major depressive disorder who don't respond to standard antidepressants can benefit when the drug therapy is augmented by a broad spectrum psychotropic agent, even when treated for a brief period of time.
Barry D. Pressman, MD, FACR, Chairman of the S. Mark Taper Foundation Imaging Center and Chief of the Section of Neuroradiology and Head and Neck Radiology at Cedars-Sinai Medical Center has been appointed to the Medicare Coverage Advisory Committee (MCAC) "“ 2007. Selected by the Secretary of the Department of Health and Human Services, MCAC members are authorities in a wide variety of scientific, clinical, and other related fields.
A new method of delivering a dose of radioactive iodine "“ using a man-made version of scorpion venom as a carrier "“ targets deadly brain tumors called gliomas without affecting neighboring tissue or body organs. After a Phase I clinical trial conducted in 18 patients showed the approach to be safe, a larger Phase II trial is underway to assess the effectiveness of multiple doses.
Cedars-Sinai Medical Center, one of the largest academic medical centers in the Western United States, has been recognized for having one of the 500 most powerful computers in the world. Cedars-Sinai's supercomputer is designed to analyze blood proteins from cancer cells and provide information that will allow researchers to more accurately predict how cancer patients will respond to specific treatments.
At the center of the story is Jose Daniel (Danny) Lozano, a teenager from Tijuana, Mexico who is recovering from reconstructive craniofacial surgery. Danny is one of many children who have received medical care made possible by a highly specialized medical team at Cedars-Sinai and a $5 million dollar gift to the hospital from actor/director Mel Gibson.
Sisters Lorena Garcia, 39, and Alma Garcia, 41, were well aware of the toll that morbid obesity had taken on their health. Alma was suffering from high blood pressure, diabetes and thyroid disease and Lorena had developed degenerative bone disease...
Cedars-Sinai Medical Center this week launched an International Stem Cell Research Institute that will conduct both adult and embryonic stem cell research. The academic medical center also announced the arrival of renowned Israeli developmental geneticist Nissim Benvenisty, M.D., Ph.D., as the institute's co-director along with David I. Meyer, Ph.D., vice president of Research and Scientific Affairs at Cedars-Sinai.
One of the world's most prominent leaders in stem cell research and its application to disease has joined Cedars-Sinai Medical Center to co-direct the new Cedars-Sinai International Stem Cell Research Institute, which will hold opening ceremonies at Cedars-Sinai on Monday, July 17, at 5 p.m. Developmental geneticist Nissim Benvenisty, M.D,. Ph.D., who is recognized worldwide for his discoveries and innovations in the development and modification of stem cells, will direct the new international institute with David I. Meyer, Ph.D., vice president of Research and Scientific Affairs at Cedars-Sinai.
Diagnosed with a carcinoid tumor, Barbara Wolfe underwent surgery at Cedars-Sinai Medical Center to have the upper lobe of her right lung and the lymph nodes in her chest removed. But the 54-year-old exercise instructor lost little time before going back to work -- five days after surgery -- thanks to the minimally invasive procedure performed by thoracic surgeon Robert McKenna Jr., M.D.
"As more and more patients seek therapy for sexual dysfunction, it is increasingly important for clinicians in a wide range of specialties to become proficient in the mechanisms and systemic effects of these medications," said Ernst R. Schwarz, M.D., Ph.D., a cardiologist at Cedars-Sinai Medical Center who specializes in therapies for men who suffer from erectile dysfunction (ED) and have heart problems, diabetes, high blood pressure or other related conditions.
Two recipients of the 2006 Pauletta and Denzel Washington Family Gifted Scholars Program in Neuroscience will receive summer research scholarship awards Wednesday, June 7 at the James A. Foshay Learning Center, 3751 S. Harvard Blvd. in Los Angeles. Pauletta and Denzel Washington will present the scholarships.
The latest advances in the etiology, diagnosis and treatment of androgen excess (excess male hormone) disorders in women will be presented at the fourth annual meeting of the Androgen Excess Society June 23 at the Hyatt Regency Boston Financial District.
Cedars-Sinai today received one of the American Stroke Association's top awards "“ "Get With the Guidelines (GWTG) "“ Stroke Initial Performance Achievement Award" "“ in recognition of its efficient and well-coordinated approach to delivering rapid, high quality care to stroke patients.
A new surgical simulation laboratory, part of the Division of Surgical Research at Cedars-Sinai Medical Center in Los Angeles, may be the first state-of-the-art simulation and training lab in California and among the first in the western United States. In addition to providing hands-on training for surgical residents and refresher opportunities for experienced surgeons, it will be used to advance the science of surgery and simulated surgery.
A recent study has shown that immune signals given by variations of a single gene can trigger different immune responses and, when combined, are associated with increased severity of Crohn's Disease, particularly in Ashkenazi Jews. The study is being presented at the annual meeting of the American Gastroenterological Association May 20-25 in Los Angeles.
Lori Dunn, who received a transplanted liver, attends weekly support group meetings as often as possible to share her experiences and offer encouragement to other patients. But because distance and schedules don't always cooperate, she often turns to an online offshoot of the group, which enables everyone to participate, no matter how far away they live or what their physical limitations may be from week to week.
Countless patients with end-stage renal failure whose immune systems had previously prevented them from receiving life-saving kidney transplants have undergone successful surgeries thanks to research led by Stanley C. Jordan, M.D., a renowned nephrologist on staff at Cedars-Sinai Medical Center. For his vanguard work demonstrating the use of intravenous immunoglobulin (IVIG) therapy to reduce the risk of organ rejection and other major contributions to the field of nephrology, Jordan received the "Spirit of Nephrology" award.
Rabbi Levi Meier, Ph.D, who serves as the Jewish Chaplain for Cedars-Sinai Medical Center in Los Angeles, has been named a 2005 National Jewish Book Award winner for his nonfiction book, Second Chances.
Jewish patients who are nearing their final hours of life often find strength and spiritual healing in holding the Torah, praying with it, or simply having it present. A small "traveling" Torah, kept in the Ark of the medical center's chapel, is now available to be taken to patient's room, often raising the spirits and morale of gravely ill individuals.
It is estimated that about two to three million women in the U.S. may suffer from undiagnosed microvascular disease, a dysfunction of the heart's small arteries. As part of its new Women's Heart Program, Cedars-Sinai Medical Center is the only center on the West Coast providing an innovative, two-step pharmacological diagnostic test aimed at this condition.
Surgery to remove herniated discs in the thoracic spine (the 12 vertebrae in the chest area of the spine) is potentially dangerous because the spinal cord is often compressed by the herniated discs. Neurosurgeons and orthopedic surgeons at the Cedars-Sinai Institute for Spinal Disorders have pioneered combining 3-D computer-guided imaging technology with endoscopic techniques to improve the surgeon's depth of field and spatial orientation, thus potentially improving the safety, accuracy and efficiency of this complex procedure.
This Mother's Day will hold special meaning for a Huntington Beach family. Their daughter is recovering from brain injuries sustained in a 2004 near-fatal automobile accident, and the girl's father is recovering from Prostate cancer surgery.
Researchers at Board of Governors' Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have developed a way to overcome immune privilege in the brain to eradicate potentially deadly brain tumors such as glioblastoma multiforme and other types of brain infections.
New anti-rejection regimes that are strong yet targeted are lowering infection rates and increasing survival rates of lung transplant patients like 61-year-old Dennis Scott, who was back at work three months after his life-saving surgery at Cedars-Sinai Medical Center.
In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.
Cedars-Sinai Medical Center today announced the appointment of Bruce Gewertz, M.D., an internationally renowned surgeon, researcher and educator with an extensive background in academic and clinical leadership, as chair of the Department of Surgery, surgeon-in-chief and vice president for interventional services.
An article in the March 1, 2006 issue of Cancer Research reports on an animal study in which bone-marrow derived neural stem cells and a newly discovered cytokine worked synergistically to track and kill glioma cells and offer long-term protection.
The medical staff at Cedars-Sinai Medical Center has elected Paul A. Silka, M.D., F.A.C.E.P., as its Chief of Staff for 2006. Silka, associate director of the department of emergency medicine since 1998, brings strong leadership and administrative experience to the position.
An international research team has provided the first conclusive evidence that neurodevelopmental disorders can be caused, at least in part, by specific gene defects that interfere with the electrical impulses of rapid-firing brain nerve cells called bursting neurons.
A study conducted at Cedars-Sinai Medical Center suggests that angioplasty with coronary stenting may be a viable alternative treatment to more complicated bypass surgery for patients with left main coronary artery (LMCA) disease when medication-releasing stents are used.
An article in the February 2006 issue of The Annals of Thoracic Surgery, describing the largest published study of the VATS procedure, says the minimally invasive approach accomplishes the same result as open surgery with low risk of complications and very good survival rates.
In his State of the Union address this past Tuesday, President Bush vowed to help revive math and science education. Tomorrow, 150 seventh- and eighth-grade students from Los Angeles area schools will attend the eighth annual "Brainworks" program hosted by the Cedars-Sinai Maxine Dunitz Neurosurgical Institute.
The Feb. 7, 2006 issue of the Journal of the American College of Cardiology includes a special supplement on the Women's Ischemia Syndrome Evaluation (WISE) Study, a multi-center, long-term investigation sponsored by the National Heart, Lung and Blood Institute.
Using a drug originally intended for diabetes treatment, researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have modified a series of intracellular biochemical events to decrease malignant brain cells' resistance to therapies that are designed to trigger a natural process of cell death.
Vagus nerve stimulator implantation, used in the treatment of epilepsy for nine years, was recently approved by the FDA as an option for patients suffering from treatment-resistant depression. Cedars-Sinai Medical Center's departments of Psychiatry and Neurosurgery are collaborating to provide this therapy.
The board of directors of Cedars-Sinai Medical Group has announced that Howard Wynne, M.D., has been named Medical Director effective April 1, 2006. Dr. Wynne will oversee the 75-member group of primary care and specialty physicians and their patient care practices.
Keith L. Black, M.D., director of Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute and the Division of Neurosurgery, will be among highly esteemed company when he receives a Trumpet Award on Monday, Jan. 23.
Although respiratory syncytial virus affects almost all children at least once before they are two years old, many parents may not be familiar with this infection which is most common during the winter season.
Neurosurgeon Adam N. Mamelak, M.D., who specializes in treating pituitary tumors and epilepsy, has joined Cedars-Sinai Medical Center and the Maxine Dunitz Neurosurgical Institute.
A gene therapy research team at Cedars-Sinai Medical Center has developed a new method of signaling therapeutic genes to turn "off" or "on," a mechanism that could enable scientists to fine-tune genetic- and stem cell-based therapies so that they are safer, more controllable and more effective.
The inaugural Warschaw Law Endowed Chair in Health Care Leadership, a permanent academic research chair at Cedars-Sinai devoted to furthering leadership, research and education in health care public policy and management, will be awarded to Thomas M. Priselac, president and CEO of Cedars-Sinai Medical Center.
While some patients, including the elderly, may not be good candidates for the physical demands of open chest surgery, a new study suggests that even those between the ages of 80 and 94 may benefit from video-assisted thoracoscopic surgery for early stage, localized, non-small cell lung cancer.
The December tipsheet from Cedars-Sinai Medical Center includes tips on holiday safety for kids, as well as story ideas on Apo A-1 Milano research, minimally invasive surgery for patients with lung cancer, an IBS study, and more.
Veins taken from a patient's leg to replace a blocked artery to the heart tend to degenerate after a few years, requiring a second bypass operation or balloon angioplasty to reopen the vessel. During an angioplasty procedure, a stent may be placed in the vessel to keep it open, but conventional metal stents often become overgrown with scar tissue.
Cedars-Sinai Health System's two physician groups that provide primary care and multi-specialty care each ranked among the top five medical groups in Los Angeles for clinical quality, patient satisfaction and use of information technology.
Cardiology researchers are studying several approaches to interrupt the events leading to the formation and rupture of atherosclerotic plaque in blood vessels. According to a recent animal study of a new gene therapy, a single injection led to a significant reduction in plaque.
Scientists and investors in Israel are international leaders in stem cell research and development. Several top researchers from Israel will join scientists and bioethicists to present a stem cell symposium at Cedars-Sinai Medical Center Nov. 16 and 17.
Researchers at Cedars-Sinai Medical Center have found that a nonabsorbable antibiotic "“ one that stays in the gut "“ may be an effective long-term treatment for irritable bowel syndrome (IBS), a disease affecting more than an estimated 20 percent of Americans.